Paper8137296
Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining.
Gillett C and 7 others. Cancer Res, 1994. Cited by 650 papers, by iCite.
Cite this record
ConductScience Library. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Papers, record 8137296. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8137296
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Chromosomes, Human, Pair 11 | Major topic |
| Cyclins | Major topic |
| Gene Amplification | Major topic |
| Oncogene Proteins | Major topic |
| Alleles | |
| Antibodies, Monoclonal | |
| Chromosome Mapping | |
| Cyclin D1 | |
| DNA, Neoplasm | |
| Female | |
| Gene Expression | |
| Humans | |
| Immunohistochemistry | |
| Prognosis | |
| RNA, Neoplasm | |
| Transcription, Genetic | |
| Tumor Cells, Cultured |
Source PubMed
Cited by236
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 650 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42629473 | Metastasis of triple negative breast cancer is regulated by a targetable miR-342-E2F network. | EMBO Mol Med | 2026 | https://conductscience.org/library/papers/42629473 | PubMed |
| 42079002 | γ-Tocotrienol inhibits HeLa cell proliferation likely via modulation of the PI3K/AKT/mTOR signaling pathway. | Front Nutr | 2026 | https://conductscience.org/library/papers/42079002 | PubMed |
| 41758262 | Altered expression and mutations in cell cycle genes CCND1, CDK4, CDKN2B and TP53 are associated with Pakistani breast cancer patients. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/41758262 | PubMed |
| 41710088 | Charting the multilevel molecular response to palbociclib in ER-positive breast cancer. | NAR Cancer | 2026 | https://conductscience.org/library/papers/41710088 | PubMed |
| 41646949 | Prognostic markers in oesophageal and gastric cancer review. Are they ready for clinical practice? | ESMO Gastrointest Oncol | 2024 | https://conductscience.org/library/papers/41646949 | PubMed |
| 40233410 | A circRNA-mRNA pairing mechanism regulates tumor growth and endocrine therapy resistance in ER-positive breast cancer. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/40233410 | PubMed |
| 40034931 | Expression of Cyclin D1 and Claudin-1 in Invasive Breast Carcinoma and Their Correlation with Clinicopathological Parameters. | Iran J Pathol | 2024 | https://conductscience.org/library/papers/40034931 | PubMed |
| 39885369 | Resistance mechanisms and therapeutic strategies of CDK4 and CDK6 kinase targeting in cancer. | Nat Cancer | 2025 | https://conductscience.org/library/papers/39885369 | PubMed |
| 39591896 | BET inhibitor and CDK4/6 inhibitor synergistically inhibit breast cancer by suppressing BRD4 stability and DNA damage repair. | Transl Oncol | 2025 | https://conductscience.org/library/papers/39591896 | PubMed |
| 39412532 | Intramammary Labeling of Epithelial Cell Division. | J Mammary Gland Biol Neoplasia | 2024 | https://conductscience.org/library/papers/39412532 | PubMed |
| 38831405 | Genome-wide in vivo CRISPR screen identifies TGFβ3 as actionable biomarker of palbociclib resistance in triple negative breast cancer. | Mol Cancer | 2024 | https://conductscience.org/library/papers/38831405 | PubMed |
| 38685777 | Envisioning Clinical Management of Breast Cancer: a Comprehensive Review. | Curr Drug Discov Technol | 2025 | https://conductscience.org/library/papers/38685777 | PubMed |
| 38082107 | The CDK4/6 inhibitor revolution - a game-changing era for breast cancer treatment. | Nat Rev Clin Oncol | 2024 | https://conductscience.org/library/papers/38082107 | PubMed |
| 37024471 | Aberrant Cyclin D1 splicing in cancer: from molecular mechanism to therapeutic modulation. | Cell Death Dis | 2023 | https://conductscience.org/library/papers/37024471 | PubMed |
| 36628275 | Non-canonical approaches to targeting hypoxic tumors. | Am J Cancer Res | 2022 | https://conductscience.org/library/papers/36628275 | PubMed |
| 36243802 | A combination of novel NSC small molecule inhibitor along with doxorubicin inhibits proliferation of triple-negative breast cancer through metabolic reprogramming. | Oncogene | 2022 | https://conductscience.org/library/papers/36243802 | PubMed |
| 36001804 | Regulation of Cyclin D1 Degradation by Ubiquitin-Specific Protease 27X Is Critical for Cancer Cell Proliferation and Tumor Growth. | Mol Cancer Res | 2022 | https://conductscience.org/library/papers/36001804 | PubMed |
| 35942997 | Immunohistochemical Overexpression of Cyclin D1 in Tunisian Invasive Breast Carcinoma Women. | Arch Iran Med | 2022 | https://conductscience.org/library/papers/35942997 | PubMed |
| 35781526 | Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunities. | J Cancer Res Clin Oncol | 2023 | https://conductscience.org/library/papers/35781526 | PubMed |
| 35595729 | Kindlin-2 promotes Src-mediated tyrosine phosphorylation of androgen receptor and contributes to breast cancer progression. | Cell Death Dis | 2022 | https://conductscience.org/library/papers/35595729 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CCND1 | 595 | PubTator's text mining | https://conductscience.org/library/genes/595 | NCBI Gene |
| CCNL2 | 81669 | PubTator's text mining | https://conductscience.org/library/genes/81669 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8137296
GET https://conductscience.org/api/papers/v1/8137296/cited_by?page=2